Navigation Links
Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease
Date:5/23/2013

l needs and typically provides priority review status.

"Cognitive impairment is a hallmark of Huntington's disease and schizophrenia, and there currently are no drugs that improve cognition in either disorder," stated Gregory A. Demopulos , M.D., chairman and chief executive officer of Omeros. "In Huntington's disease, OMS824 also has the potential to improve motor control and to reduce the rate of neurodegeneration, slowing disease progression. We are pleased that the FDA has now cleared the way for us to evaluate OMS824 in both patients with Huntington's disease and schizophrenia, and we look forward to initiating enrollment in our Phase 2 clinical trials."

About Orphan Drug Status
Orphan drug designation is granted by the FDA's Office of Orphan Products Development for drugs that are expected to provide significant therapeutic advantage over existing treatments and that target conditions affecting 200,000 or fewer U.S. patients annually. Orphan drug designation qualifies a company for several benefits under the Orphan Drug Act of 1983. The benefits apply across all stages of drug development and include accelerated approval process; seven years of market exclusivity following marketing approval; tax credits on U.S. clinical trials; eligibility for orphan drug grants; and waiver of certain administrative fees.

About FDA's Fast Track Program
The FDA's Fast Track program facilitates the development of drugs intended to treat serious or life-threatening conditions and that have the potential to address unmet medical needs. Fast Track drugs are eligible for more frequent and timely meetings with the FDA to discuss the development plan and to ensure that data needed for approval are collected appropriately. Drugs in the Fast Track program typically are granted priority review status and their respective New Drug Applications are accepted and reviewed by the FDA as rolling submissions.

About Omeros' PDE1
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
2. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
3. Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
4. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
5. AbbVies Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
6. Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia
7. Bayers Investigational Riociguat Granted U.S. FDA Priority Review for Pulmonary Arterial Hypertension and Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
8. Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013
9. European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Companys empagliflozin*, an investigational type 2 diabetes treatment
10. Boehringer Ingelheim and Eli Lilly and Company submit new drug application to FDA for empagliflozin, an investigational type 2 diabetes treatment
11. Genocea Publishes Preclinical Data For Investigational Vaccine Candidate For HSV-2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... , Aug. 30, 2014  Boston Scientific ... NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical ... trial investigating vagus nerve stimulation (VNS) for the ... Ph.D., Professor of Therapeutics and Cardiology and Director ... National de la Sante et de la Recherche ...
(Date:8/30/2014)...   Royal Philips  (NYSE: PHG, AEX: PHIA) today ... ultrasound system designed to enable global hospitals and health ... and cost pressures. Making its debut at the  European ... Barcelona this week, Affiniti provides innovative technology ... resources deliver high quality patient care. ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- Market Research Report ... 2009-2019 is a professional and in-depth market survey ... industry . The report firstly reviews the basic ... application and manufacturing technology. The report then explores ... Scanner listing their product specification, capacity, Production value, ...
Breaking Medicine Technology:Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5
... Osteotech, Inc. (Nasdaq: OSTE ), a leader in the ... the Company,s first quarter ended March 31, 2010 financial ... May 10, 2010 .  The management team of Osteotech will host ... , at 9:00 a.m. (EDT) to discuss the Company,s ...
... Doctora Aliza, editor in chief of VidaySalud.com and expert health commentator for the ... Latino Legislative Caucus during a special Assembly floor session at the California Capitol ... , (Photo: ... "Doctor Aliza ...
Cached Medicine Technology:Osteotech Announces First Quarter 2010 Financial Results Release and Conference Call 2Latino Spirit Award For VidaySalud.com's Doctora Aliza 2
(Date:8/31/2014)... Obese youths have a nearly six fold risk ... ,22 000 young people from the PEP Family ... Professor Peter Schwandt from Germany. , Professor Schwandt ... children and adolescents is continuing to rise in ... considered a driving force for cardiovascular disease, we ...
(Date:8/31/2014)... California (PRWEB) August 31, 2014 ... environmentally harmful disc brake dust at the source ... , Problem: Millions of vehicles globally emit brake ... ingredients in the friction materials (disc brake pads) ... the nations’ water systems. For example, copper impairs ...
(Date:8/31/2014)... 2014 Priya Khan, Director of ... concern over misinformation about weight-loss supplements saying, “Consumers ... often, misleading information being propagated by unscrupulous companies ... are weighing in on the subject. , NutriGold’s ... and especially weight-loss products and to provide them ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 To make ... supplement brand they can trust, NutriGold is shipping complimentary ... A form has been set up to make taking ... , According to Priya Khan, Director of Research ... customers purchase one of our products, they are entrusting ...
(Date:8/31/2014)... 2014 “Prohibition is our history,” ... our future: the present ~ that’s political.” , ... , new on the Bryan William Brickner Blog, ... system (CS) modulation and homeostasis - including one ... use. The Publius CS update includes: heteromerization ...
Breaking Medicine News(10 mins):Health News:Obese youths have a nearly 6 fold risk of hypertension 2Health News:CBPModular Technology with Global Patent Coverage Solves Vehicle Wheel Brake Dust Problem 2Health News:New Reasons to Verify Label Claims on Weight-loss Products Before Buying 2Health News:New Reasons to Verify Label Claims on Weight-loss Products Before Buying 3Health News:Whole-food Supplement Samples Now Offered by NutriGold 2Health News:Whole-food Supplement Samples Now Offered by NutriGold 3Health News:Homeostasis: Publius’ Alcohol Political Cannabinoid Science ~ New on the Bryan William Brickner Blog 2
... of Michigan evolutionary biologist Jianzhi "George" Zhang, has uncovered ... a sex determiner in honey bees. These novel inputs ... methods to breed honeybees, who are effective pollinators of ... findings of Zhang and collaborators are published in a ...
... to pain.In the study conducted on rats, the development// ... expression of that particular gene after a nerve injury ... of new painkillers. ,"Studies in volunteers showed ... variant that protects them from pain somewhat, and three ...
... disease is to be resumed and researchers from Southampton University ... ,The progress of the disease was supposed to be reversed ... the disease. But during the second phase of the trial, ... the study was brought to a halt for safety ...
... plastic and reconstructive surgeon has been given the go-ahead ... the Royal Free Hospital, London to select four patients ... College of Surgeons has called for caution with leading ... surgery promises to transform the lives of hundreds of ...
... implanted in 65,000 dogs in Shanghai to improve canine management ... at curbing// rabies in provinces of Yunnan and Shandong drew ... ID number. To access information about the dog - photo, ... have to access the ID number. ,Chip developer ...
... Gleneagles Hospitals has asked the West Bengal government for 10 ... here for setting up// a Rs.1.5 billion institute. ... research in the medical field, said V. Satyanarayana Reddy, CEO, ... the government to identify and hand over a site for ...
Cached Medicine News:Health News:Breeding success by delving into the honey bee sex gene 2Health News:Breeding success by delving into the honey bee sex gene 3Health News:Gene determines pain threshold... 2Health News:Alzheimer's Vaccine- A Realistic Prospect 2Health News:Green Signal given to Full-Face Transplants 2Health News:Green Signal given to Full-Face Transplants 3
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Infusion Cannula, 6.0mm....
Subretinal Aspiration Cannula, Curved; 20g (0.90) x 1" (25mm); Tip Extension: 6.5mm, 27g (0.40); Angled at 60°, 2.5mm from Tip....
Subretinal Fluid Cannula, Straight; 20g (0.90) x 1-1/2" (38mm); 12mm Flexible Tubing Extends 6mm Beyond Tip....
Medicine Products: